ArticleBlood2007

High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Ji Suk Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.